Tysabri (natalizumab) is a brand-name intravenous (IV) infusion. It’s prescribed for adults with Crohn’s disease or certain forms of multiple sclerosis. Tysabri has interactions with some ...

As temperatures rise in Metro Manila, the Japan Travel Fair 2025 is set to offer a refreshing escape for Filipinos eager to discover the wonders of Japan. On February 22 and 23, the Glorietta ...

Polpharma Biologics has said it is the first company to get approval in the EU for a biosimilar version of Biogen’s blockbuster multiple sclerosis therapy Tysabri. The European Commission has ...

Polpharma Biologics has become the first company to file for approval in the EU of a biosimilar version of Biogen's blockbuster multiple sclerosis therapy Tysabri. The biotech – headquartered in ...